Suvorexant(MK-4305)
Modify Date: 2024-01-03 15:03:19
Suvorexant(MK-4305) structure
|
Common Name | Suvorexant(MK-4305) | ||
|---|---|---|---|---|
| CAS Number | 1030377-33-3 | Molecular Weight | 450.921 | |
| Density | 1.4±0.1 g/cm3 | Boiling Point | 669.8±65.0 °C at 760 mmHg | |
| Molecular Formula | C23H23ClN6O2 | Melting Point | 153℃ | |
| MSDS | N/A | Flash Point | 358.9±34.3 °C | |
Use of Suvorexant(MK-4305)Suvorexant (MK-4305) is a potent, selective, and orally bioavailable antagonist of OX1R and OX2R currently under clinical investigation as a novel therapy for insomnia. |
| Name | suvorexant |
|---|---|
| Synonym | More Synonyms |
| Density | 1.4±0.1 g/cm3 |
|---|---|
| Boiling Point | 669.8±65.0 °C at 760 mmHg |
| Melting Point | 153℃ |
| Molecular Formula | C23H23ClN6O2 |
| Molecular Weight | 450.921 |
| Flash Point | 358.9±34.3 °C |
| Exact Mass | 450.157104 |
| PSA | 80.29000 |
| LogP | 3.62 |
| Vapour Pressure | 0.0±2.0 mmHg at 25°C |
| Index of Refraction | 1.703 |
| Hazard Codes | Xi |
|---|
CAS#:956317-36-5![(R)-5-chloro-2-(5-Methyl-1,4-diazepan-1-yl)benzo[d]oxazole Structure](https://www.chemsrc.com/caspic/317/1266975-27-2.png)
CAS#:1266975-27-2
CAS#:3621-81-6![(R)-4-(5-Chlorobenzo[d]oxazol-2-yl)-7-methyl-1,4-diazepan-1-ium (2S,3S)-2,3-bis(benzoyloxy)-3-carboxypropanoate Structure](https://www.chemsrc.com/caspic/405/1276666-14-8.png)
CAS#:1276666-14-8
CAS#:52548-14-8
CAS#:1104546-96-4
CAS#:95-85-2| Belsomra |
| [(7R)-4-(5-Chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone |
| [(7R)-4-(5-chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl]-[5-methyl-2-(triazol-2-yl)phenyl]methanone |
| [(R)-4-(5-chlorobenzoxazol-2-yl)-7-methyl-[1,4]diazepan-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)methanone |
| Methanone, [(7R)-4-(5-chloro-2-benzoxazolyl)hexahydro-7-methyl-1H-1,4-diazepin-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]- |
| [(R)-4-(5-chlorobenzooxazol-2-yl)-7-methyl-[1,4]diazepan-1-yl](5-methyl-2-[1,2,3]triazol-2-yl-phenyl)methanone |
| Suvorexant |
| 5-chloro-2-{(5R)-5-methyl-4-[5-methyl-2-(2H-1,2,3-triazol-2-yl)benzoyl]-1,4-diazepan-1-yl}-1,3-benzoxazole |
| DORA-analogue |
| [(7R)-4-(5-chlorobenzoxazol-2-yl)-7-methylhexahydro-1H-1,4-diazepin-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone |
| MK-4305 |